TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
54.53
+1.23 (2.31%)
At close: Oct 20, 2026, 4:00 PM EDT
54.60
+0.07 (0.13%)
Pre-market: Oct 21, 2026, 5:06 AM EDT
TG Therapeutics Market Cap
TG Therapeutics has a market cap or net worth of $7.73 billion as of October 20, 2026. It is the 2,615th most valuable company in the world and the 890th biggest in the United States. Its market cap has increased by 40.61% in one year.
Market Cap
7.73B
Enterprise Value
7.94B
1-Year Change
40.61%
Global Rank
Country Rank
#890 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, TG Therapeutics's market cap has increased from $34.90M to $7.73B, an increase of 22,063.26%. That is a compound annual growth rate of 21.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 8.16B | 72.39% |
| Dec 31, 2025 | 4.73B | 1.01% |
| Dec 31, 2024 | 4.69B | 81.18% |
| Dec 29, 2023 | 2.59B | 50.41% |
| Dec 30, 2022 | 1.72B | -36.69% |
| Dec 31, 2021 | 2.72B | -60.29% |
| Dec 31, 2020 | 6.84B | 518.96% |
| Dec 31, 2019 | 1.11B | 225.13% |
| Dec 31, 2018 | 339.90M | -41.33% |
| Dec 29, 2017 | 579.30M | 127.62% |
| Dec 30, 2016 | 254.50M | -59.38% |
| Dec 31, 2015 | 626.60M | -10.02% |
| Dec 31, 2014 | 696.40M | 433.23% |
| Dec 31, 2013 | 130.60M | 43.20% |
| Dec 31, 2012 | 91.20M | 91,100.00% |
| Dec 30, 2011 | 100.00K | -95.45% |
| Dec 31, 2010 | 2.20M | -58.49% |
| Dec 31, 2009 | 5.30M | 783.33% |
| Dec 31, 2008 | 600.00K | -90.63% |
| Dec 31, 2007 | 6.40M | -86.18% |
| Dec 29, 2006 | 46.30M | -38.35% |
| Dec 30, 2005 | 75.10M | 181.27% |
| Dec 31, 2004 | 26.70M | -27.64% |
| Dec 31, 2003 | 36.90M | 623.53% |
| Dec 31, 2002 | 5.10M | -49.50% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Twist Bioscience | 8.76B |
| Cytokinetics | 8.71B |
| Protagonist Therapeutics | 8.70B |
| Caris Life Sciences | 8.68B |
| Axsome Therapeutics | 8.16B |
| Arrowhead Pharmaceuticals | 8.08B |
| Spyre Therapeutics | 7.92B |
| ABIVAX Société Anonyme | 7.62B |